Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Plast Reconstr Surg. 2019 Jun;143(6):1159e–1168e. doi: 10.1097/PRS.0000000000005602

Table 1.

Patient Characteristics by Reconstruction Laterality and Procedure Type

Variable Unilateral
Bilateral
Implant Autologous p Implant Autologous p
No. patients 600 317 994 214
Age 52.5 (10.3) 52.7 (8.9) 0.746 45.9 (9.7) 49.8 (8.0) <.001
BMI 26.2 (5.3) 28.3 (5.2) <.001 25.3 (5.3) 30.0 (5.9) <.001
Indication for mastectomy
 Therapeutic 575 (95.8%) 309 (97.5%) 0.204 835 (84.0%) 166 (77.6%) 0.024
 Prophylactic 25 (4.2%) 8 (2.5%) 159 (16.0%) 48 (22.4%)
Mastectomy type
 Nipple sparing 70 (11.7%) 8 (2.5%) <.001 216 (21.7%) 8 (3.7%) <.001
 Simple or modified radical 530 (88.3%) 309 (97.5%) 778 (78.3%) 206 (96.3%)
Lymph node biopsy
 SLNB 301 (50.2%) 189 (59.6%) <.001 474 (47.7%) 96 (44.9%) <.001
 ALND 216 (36.0%) 73 (23.0%) 276 (27.8%) 29 (13.6%)
 None 83 (13.8%) 55 (17.4%) 244 (24.5%) 89 (41.6%)
Smoking status
 None smoker 393 (66.3%) 189 (59.6%) 0.085 674 (68.6%) 118 (55.7%) 0.001
 Previous smoker 187 (31.5%) 116 (36.6%) 285 (29.0%) 88 (41.5%)
 Current smoker 13 (2.2%) 12 (3.8%) 24 (2.4%) 6 (2.8%)
Diabetes
 Yes 26 (4.3%) 24 (7.6%) 0.040 20 (2.0%) 10 (4.7%) 0.023
 No 574 (95.7%) 293 (92.4%) 974 (98.0%) 204 (95.3%)
Radiation
 Before reconstruction 24 (4.0%) 53 (16.7%) <.001 60 (6.0%) 37 (17.3%) <.001
 During/after reconstruction 137 (22.8%) 86 (27.1%) 192 (19.3%) 33 (15.4%)
 None 439 (73.2%) 178 (56.2%) 742 (74.6%) 144 (67.3%)
Chemotherapy
 During/after reconstruction 210 (35.0%) 120 (37.9%) 0.392 312 (31.4%) 52 (24.3%) 0.040
 Not during/after reconstruction 390 (65.0%) 197 (62.1%) 682 (68.6%) 162 (75.7%)